|
[1]LISMAN T, LEEBEEK FW, de GROOT PG.Haemostatic abnormalities in patients with liver disease[J].J Hepatol, 2002, 37 (2) :280-287.
|
|
[2]CHEN J, CONG YL.Changes of hemostatic indexes in chronic hepatitis B, liver cirrhosis and liver failure[J].Chin J Lab Med, 2015, 38 (2) :128-130. (in Chinese) 陈静, 丛玉隆.止凝血相关指标在慢性乙型肝炎与肝硬化及肝衰竭中的变化趋势[J].中华检验医学杂志, 2015, 38 (2) :128-130.
|
|
[3]LISMAN T, BERNAL W.Management of hemostatic disorders in patients with advanced liver disease admitted to an intensive care unit[J].Transfus Med Rev, 2017, 31 (4) :245-251.
|
|
[4]TRIPODI A, MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med, 2011, 365 (2) :147-156.
|
|
[5]LI JT, ZHANG ML.Clinical analysis of 2 cases of liver cirrhosis complicated with venous thrombosis of lower extremity[J].Chin JMed Offic, 2018, 46 (3) :376. (in Chinese) 李军婷, 张美琳.肝硬化并下肢静脉血栓形成2例临床分析[J].临床军医杂志, 2018, 46 (3) :376.
|
|
[6]AGARWAL B, GATT A, RIDDELL A, et al.Hemostasis in patients with acute kidney injury secondary to acute liver failure[J].Kidney Int, 2013, 84 (1) :158-163.
|
|
[7]HUGENHOLTZ GC, MACRAE F, ADELMEIJER J, et al.Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen[J].JThromb Haemost, 2016, 14 (5) :1054-1066.
|
|
[8]LISMAN T, BONGERS TN, ADELMEIJER J, et al.Elevated levels of von willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity[J].Hepatology, 2006, 44 (1) :53-61.
|
|
[9]HUGENHOLTZ GC, ADELMEIJER J, MEIJERS JC, et al.An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure:implications for hemostasis and clinical outcome[J].Hepatology, 2013, 58 (2) :752-761.
|
|
[10]LISMAN T, LEEBEEK FW, MOSNIER LO, et al.Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis[J].Gastroenterology, 2001, 121 (1) :131-139.
|
|
[11]LISMAN T, PORTE RJ.Value of preoperative hemostasis testing in patients with liver disease for perioperative hemostatic management[J].Anesthesiology, 2017, 126 (2) :338-344.
|
|
[12]NAPOLITANO G, IACOBELLIS A, MERLA A, et al.Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia[J].Eur J Intern Med, 2017, 38:79-82.
|
|
[13]SEEFF LB, EVERSON GT, MORGAN TR, et al.Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial[J].Clin Gastroenterol Hepatol, 2010, 8 (10) :877-883.
|
|
[14]de GOTTARDI A, THEVENOT T, SPAHR L, et al.Risk of complications after abdominal paracentesis in cirrhotic patients:a prospective study[J].Clin Gastroenterol Hepatol, 2009, 7 (8) :906-909.
|
|
[15]PERDIGAO JP, de ALMEIDA PC, ROCHA TD, et al.Postoperative bleeding after dental extraction in liver pretransplant patients[J].J Oral Maxillofac Surg, 2012, 70 (3) :e177-184.
|
|
[16]MASSICOTTE L, THIBEAULT L, ROY A.Classical notions of coagulation revisited in relation with blood losses, transfusion rate for700 consecutive liver transplantations[J].Semin Thromb Hemost, 2015, 41 (5) :538-546.
|
|
[17]MASSICOTTE L, BEAULIEU D, THIBEAULT L, et al.Coagulation defects do not predict blood product requirements during liver transplantation[J].Transplantation, 2008, 85 (7) :956-962.
|
|
[18]LEVI M, van der POLL T.Coagulation and sepsis[J].Thromb Res, 2017, 149:38-44.
|
|
[19]SENZOLO M, CHOLONGITAS E, THALHEIMER U, et al.Heparin-like effect in liver disease and liver transplantation[J].Clin Liver Dis, 2009, 13 (1) :43-53.
|
|
[20]AMBROSINO P, TARANTINO L, Di MINNO G, et al.The risk of venous thromboembolism in patients with cirrhosis.A systematic review and meta-analysis[J].Thromb Haemost, 2017, 117 (1) :139-148.
|
|
[21]VALLA D.Splanchnic vein thrombosis[J].Semin Thromb Hemost, 2015, 41 (5) :494-502.
|
|
[22]TANG W, WANG Y, ZHAO XY, et al.Impact of portal vein thrombosis on prognosis of patients with liver cirrhosis[J].J Clin Heptal, 2017, 33 (3) :466-471. (in Chinese) 汤雯, 王宇, 赵新颜, 等.门静脉血栓对肝硬化患者预后的影响[J].临床肝胆病杂志, 2017, 33 (3) :466-471.
|
|
[23]COOK D, CROWTHER M, MEADE M, et al.Deep venous thrombosis in medical-surgical critically ill patients:prevalence, incidence, and risk factors[J].Crit Care Med, 2005, 33 (7) :1565-1571.
|
|
[24]HUGENHOLTZ GC, NORTHUP PG, PORTE RJ, et al.Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?[J].Blood Rev, 2015, 29 (2) :127-136.
|
|
[25]MOOREHEAD KJ, JEFFRES MN, MUELLER SW.A retrospective cohort analysis of pharmacologic VTE prophylaxis and padua prediction score in hospitalized patients with chronic liver disease[J].JPharm Pract, 2017, 30 (1) :58-63.
|
|
[26]POTZE W, ARSHAD F, ADELMEIJER J, et al.Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis[J].PLo S One, 2014, 9 (2) :e88390.
|
|
[27]HANIFY JM, DUPREE LH, JOHNSON DW, et al.Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis[J].J Crit Care, 2017, 37:206-210.
|
|
[28] KEARON C, AKL EA, COMEROTA AJ, et al.Antithrombotic therapy for VTE disease:Antithrombotic therapy and prevention of thrombosis, 9th ed:american college of chest physicians evidence-based clinical practice guidelines[J].Chest, 2012, 141 (Suppl2) :e419S-e496S.
|
|
[29]CHEN DF, XIONG J.Advances in mechanisms and treatment of portal vein thrombosis in patients with liver cirrhosis[J].J Clin Hepatol, 2017, 33 (3) :451-453. (in Chinese) 陈东风, 熊吉.肝硬化门静脉血栓形成的机制与治疗进展[J].临床肝胆病杂志, 2017, 33 (3) :451-453.
|
|
[30]NORTHUP PG, SUNDARAM V, FALLON MB, et al.Hypercoagulation and thrombophilia in liver disease[J].J Thromb Haemost, 2008, 6 (1) :2-9.
|
|
[31]DROLZ A, HORVATITS T, ROEDL K, et al.Coagulation parameters and major bleeding in critically ill patients with cirrhosis[J].Hepatology, 2016, 64 (2) :556-568.
|
|
[32]ALKOZAI EM, LISMAN T, PORTE RJ.Bleeding in liver surgery:prevention and treatment[J].Clin Liver Dis, 2009, 13 (1) :145-154.
|
|
[33]SPIESS BD.Transfusion of blood products affects outcome in cardiac surgery[J].Semin Cardiothorac Vasc Anesth, 2004, 8 (4) :267-281.
|
|
[34]de BOER MT, CHRISTENSEN MC, ASMUSSEN M, et al.The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation[J].Anesth Analg, 2008, 106 (1) :32-44.
|
|
[35]TOY P, GAJIC O, BACCHETTI P, et al.Transfusion-related acute lung injury:incidence and risk factors[J].Blood, 2012, 119 (7) :1757-1767.
|
|
[36]WEEDER PD, PORTE RJ, LISMAN T.Hemostasis in liver disease:implications of new concepts for perioperative management[J].Transfus Med Rev, 2014, 28 (3) :107-113.
|
|
[37]NORTHUP PG, CALDWELL SH.Coagulation in liver disease:a guide for the clinician[J].Clin Gastroenterol Hepatol, 2013, 11 (9) :1064-1074.
|
|
[38]MULLER MC, ARBOUS MS, SPOELSTRA-DE MAN AM, et al.Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures:a randomized clinical trial (CME) [J].Transfusion, 2015, 55 (1) :26-35;quiz 25.
|
|
[39]JIA Q, BROWN MJ, CLIFFORD L, et al.Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests:a single-institution propensity-adjusted cohort study[J].Lancet Haematol, 2016, 3 (3) :e139-148.
|
|
[40]STANWORTH SJ, WALSH TS, PRESCOTT RJ, et al.A national study of plasma use in critical care:Clinical indications, dose and effect on prothrombin time[J].Crit Care, 2011, 15 (2) :R108.
|
|
[41]LISMAN T, STRAVITZ RT.Rebalanced hemostasis in patients with acute liver failure[J].Semin Thromb Hemost, 2015, 41 (5) :468-473.
|
|
[42]MALLETT SV.Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients with liver disease and during liver transplantation[J].Semin Thromb Hemost, 2015, 41 (5) :527-537.
|
|
[43]KIRCHNER C, DIRKMANN D, TRECKMANN JW, et al.Coagulation management with factor concentrates in liver transplantation:a single-center experience[J].Transfusion, 2014, 54 (10 Pt 2) :2760-2768.
|
|
[44]ROBERTS LN, BERNAL W.Management of bleeding and thrombosis in critically ill patients with liver disease[J].Semin Thromb Hemost, 2015, 41 (5) :520-526.
|
|
[45]MEYER AV, GREEN M, PAUTLER HM, et al.Impact of vitamin K administration on INR changes and bleeding events among patients with cirrhosis[J].Ann Pharmacother, 2016, 50 (2) :113-117.
|
|
[46]SAJA MF, ABDO AA, SANAI FM, et al.The coagulopathy of liver disease:does vitamin K help?[J].Blood Coagul Fibrinolysis, 2013, 24 (1) :10-17.
|
DownLoad: